Skip to main content

Advertisement

Log in

High Levels of Il-19 in Patients with Chronic Inflammatory Demyelinating Polyneuropathy

  • Published:
Journal of Molecular Neuroscience Aims and scope Submit manuscript

Abstract

Immune-mediated neuropathies include some specific types such as acute and chronic inflammatory demyelinating polyneuropathy (AIDP and CIDP). Previous studies have demonstrated abnormal cellular or humoral immune responses in these conditions. Although aberrant regulation of several cytokines have been reported in AIDP and CIDP, the significance of interleukin 19 (IL-19) in these conditions have not been elucidated yet. In the current study, we assessed serum levels of IL-19 in 12 CIDP patients (female/male ratio, 4/8), 9 AIDP patients (female/male ratio, 3/6), and 27 normal subjects (female/male ratio. 8/19) using commercial ELISA kits. Notably, we detected higher levels of this cytokine in CIDP patients (136.4 ± 8.57 ng/l) compared with both AIDP patients (93.89 ± 2.26 ng/l) and controls (83.78 ± 1.72 ng/l). However, the differences between AIDP patients and controls were not significant. The current study demonstrates the role of IL-19 in the pathogenesis of CIDP and potentiates this cytokine as a biomarker for this condition.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  • Abd Nikfarjam B, Ebtekar M, Sabouni F, Pourpak Z, Kheirandish M (2013) Detection of IL-20R1 and IL-20R2 mRNA in C57BL/6 mice astroglial cells and brain cortex following LPS stimulation. Iran J Immunol 10:62–69

    CAS  PubMed  Google Scholar 

  • Ali ZPM, Ghafouri-Fard S, Komaki A, Mazdeh M, Taheri M, Eftekharian MM (2020) Assessment of IL-38 levels in patients with acquired immune-mediated polyneuropathies. J Mol Neurosci

  • Blumberg H, Conklin D, Xu W, Grossmann A, Brender T, Carollo S, Eagan M, Foster D, Haldeman BA, Hammond A (2001) Interleukin 20: discovery, receptor identification, and role in epidermal function. Cell 104:9–19

    Article  CAS  Google Scholar 

  • Chandra SR, Karru VR, Mukheem Mudabbir MA, Ramakrishnan S, Mahadevan A (2018) Immune-mediated neuropathies our experience over 3 years. Journal of neurosciences in rural practice 9:30–35

    Article  Google Scholar 

  • Chang C, Magracheva E, Kozlov S, Fong S, Tobin G, Kotenko S, Wlodawer A, Zdanov A (2003) Crystal structure of interleukin-19 defines a new subfamily of helical cytokines. J Biol Chem 278:3308–3313

    Article  CAS  Google Scholar 

  • Chi LJ, Xu WH, Zhang ZW, Huang HT, Zhang LM, Zhou J (2010) Distribution of Th17 cells and Th1 cells in peripheral blood and cerebrospinal fluid in chronic inflammatory demyelinating polyradiculoneuropathy. J Peripher Nerv Syst 15:345–356

    Article  CAS  Google Scholar 

  • Hsu YH, Hsieh PP, Chang MS (2012) Interleukin-19 blockade attenuates collagen-induced arthritis in rats. Rheumatology (Oxford) 51:434–442

    Article  CAS  Google Scholar 

  • Köller H, Kieseier BC, Jander S, Hartung H-P (2005) Chronic inflammatory demyelinating polyneuropathy. N Engl J Med 352:1343–1356

    Article  Google Scholar 

  • Lehmann HC, Meyer Zu Horste G, Kieseier BC, Hartung H-P (2009) Pathogenesis and treatment of immune-mediated neuropathies. Ther Adv Neurol Disord 2:261–281

    Article  Google Scholar 

  • Liao SC, Cheng YC, Wang YC, Wang CW, Yang SM, Yu CK, Shieh CC, Cheng KC, Lee MF, Chiang SR, Shieh JM, Chang MS (2004) IL-19 induced Th2 cytokines and was up-regulated in asthma patients. J Immunol 173:6712–6718

    Article  CAS  Google Scholar 

  • (1991) Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Neurology 41:617–618

  • Nyati KK, Prasad KN (2014) Role of cytokines and toll-like receptors in the immunopathogenesis of Guillain-Barré syndrome. Mediat Inflamm 2014:758639–758639

    Article  Google Scholar 

  • Ouyang W, Rutz S, Crellin NK, Valdez PA, Hymowitz SG (2011) Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu Rev Immunol 29:71–109

    Article  CAS  Google Scholar 

  • Van Der Meche FG, Van Doorn PA, Meulstee J, Jennekens FG (2001) Diagnostic and classification criteria for the Guillain-Barre syndrome. Eur Neurol 45:133–139

    Article  Google Scholar 

Download references

Acknowledgments

The current study was supported by a grant number 9712218216 from Hamadan University of Medical Sciences.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Mohammad Taheri or Mohammad Mahdi Eftekharian.

Ethics declarations

Conflict of Interest

The authors declare they have no conflict of interest.

The study protocol was approved by the ethical committee of Hamadan University of Medical Sciences (IR.UMSHA.REC.1397.948). All study participants signed the informed consent forms.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sangsefidi, S., Ghafouri-Fard, S., Komaki, A. et al. High Levels of Il-19 in Patients with Chronic Inflammatory Demyelinating Polyneuropathy. J Mol Neurosci 70, 1997–2000 (2020). https://doi.org/10.1007/s12031-020-01602-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12031-020-01602-y

Keywords

Navigation